Franklin A. Neva followed by service with the US Navy at Naval Medical Research Unit-3 in Cairo, Egypt. He spent several years at Harvard University as a researcher. He became a professor at University of Pittsburgh, where he worked with Jonas Salk on a vaccine for polio. While at Pittsburgh, he also isolated ECHO 16, the virus responsible for Boston exanthem disease. This was the first description of that disease. Together with Thomas Weller, he isolated the Rubella virus in 1962. In 1964 he moved back to Harvard to head the Department of Tropical Public Health. In 1969 he joined the National Institutes
Influenza vaccine sera (chiefly against what we now call "Hemophilus influenzae"—a name derived from the fact that it was originally considered the etiological agent—and several types of pneumococci). Only one therapeutic measure, transfusing blood from recovered patients to new victims, showed any hint of success." In 1931, viral growth in embryonated hens' eggs was reported by Ernest William Goodpasture and colleagues at Vanderbilt University. The work was extended to growth of influenza virus by several workers, including Thomas Francis, Jonas Salk, Wilson Smith and Macfarlane Burnet, leading to the first experimental influenza vaccines. In the 1940s, the US military developed the first